JG
CTKB icon

Jain Global’s Cytek Biosciences CTKB Stock Holding History

Jain Global’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
+411,465
New +$1.76M 0.01% 808

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jain Global's CTKB Position: Q2 2026 in Review

Jain Global opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 411,465 shares worth $1.82M. The stake represents 0.01% of the portfolio and ranks #808 among its holdings.

155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Jain Global held 411,465 shares of Cytek Biosciences worth $1.82M as of Q2 2026.
  • Cytek Biosciences was a new Jain Global position in Q2 2026.
  • Cytek Biosciences made up 0.01% of Jain Global's portfolio in Q2 2026, its #808 holding.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.